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SUMMARY
A large portion of common variant loci associated with genetic risk for schizophrenia reside 
within non-coding sequence of unknown function. Here, we demonstrate promoter and enhancer 
enrichment in schizophrenia variants associated with expression quantitative trait loci (eQTL). 
The enrichment is greater when functional annotations derived from human brain are used relative 
to peripheral tissues. Regulatory trait concordance analysis ranked genes within schizophrenia 
genome-wide significant loci for a potential functional role, based on co-localization of a risk 
SNP, eQTL and regulatory element sequence. We identified potential physical interactions of non-
contiguous proximal and distal regulatory elements. This was verified in prefrontal cortex and 
induced pluripotent stem cell-derived neurons for the L-type calcium channel (CACNA1C) risk 
locus. Our findings point to a functional link between schizophrenia-associated non-coding SNPs 
and 3-dimensional genome architecture associated with chromosomal loopings and transcriptional 
regulation in the brain.
INTRODUCTION
A recent multi-stage genome-wide association study (GWAS) in schizophrenia (SCZ) 
identified 22 linkage disequilibrium (LD) independent loci that reached genome-wide 
significance (Ripke et al., 2013). The majority of identified SNPs reside within non-coding 
regions of genes or in intergenic regions. Furthermore, the regions were frequently large and 
often contained multiple implicated SNPs due to local LD patterns. In order to be able to 
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understand these associations mechanistically, it is important to develop strategies for 
honing in on regions and SNPs more likely to have functional effects. Thus, the elucidation 
of the function of non-coding disease-associated loci is an important next step towards the 
development of testable hypotheses regarding biological processes involved in the 
pathogenesis of SCZ.
Across many phenotypes, non-coding GWAS risk loci are involved in the regulation of 
transcriptional activity and demonstrate enrichment for expression quantitative trait loci 
(eQTL) (Nicolae et al., 2010; Richards et al., 2012; Zhong et al., 2010) and cis-regulatory 
elements (CREs) (Degner et al., 2012; Harismendy et al., 2011; Maurano et al., 2012; 
Musunuru et al., 2010). A CRE, such as a promoter or an enhancer, is a non-coding DNA 
sequence in, near or distal to a gene that contains binding sites for regulatory factors and is 
required for proper spatiotemporal expression of the gene. Long-distance enhancers are 
thought to interact physically with gene proximal promoters and transcription start sites 
(TSS) by forming loops through regulatory proteins including cohesins and other repressors 
and facilitators of transcription (Fanucchi et al., 2013; Kagey et al., 2010). Because these 
chromosomal loopings can bypass hundreds of kilobases on the linear genome, risk loci 
positioned within CREs at a distance from the TSS could affect the binding of these 
regulatory proteins, and ultimately lead to allele-specific differences in target gene 
expression and subsequent alterations in molecular pathways implicated in disease.
In this study, we use functional annotations to categorize GWAS SNPs and demonstrate that 
variants increasing risk for SCZ are enriched for alleles that affect gene expression (eSNPs) 
and lie within promoters or enhancers. The enrichment shows tissue specificity and is 
greatest when functional annotations derived from human cerebral cortex are used. For ten 
out of 22 SCZ GWAS hits, we identify functional variants positioned within promoters, 
enhancers and other regulatory sequences that are associated with expression of 13 genes. 
For the L-type calcium channel (CACNA1C), a well-established SCZ risk locus, we map 
non-contiguous physical interactions between enhancer regions and the TSSs using human 
postmortem brain tissue and human induced pluripotent stem cells (hiPSCs) derived 
neurons. Overall, this study provides a functional link between SCZ non-coding risk loci and 
physical interactions of non-contiguous DNA elements associated with transcriptional 
regulation in the human brain.
RESULTS
Enrichment of functional annotation categories in SCZ
We primarily used publically available data to generate functional annotations. Brain eSNPs 
were generated by using genotype and gene expression profiles from 8 datasets (Colantuoni 
et al., 2011; Gibbs et al., 2010; Zhang, 2013) (Table S1). The brain CRE annotation map 
was generated based on chromatin immunoprecipitation followed by high-throughput 
sequencing (ChIP-seq) experiments of histone modifications (Cheung et al., 2010; Maurano 
et al., 2012; Shulha et al., 2013; Shulha et al., 2012; Zhu et al., 2013) (Table S2, S3). We 
integrated data from specific sets of histone methylation and acetylation markings and 
DNase I hypersensitive sites (DHS) to define five types of CREs: active promoter, active 
enhancer, poised promoter, repressed enhancer and open chromatin regions.
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Genome-wide SNPs from a published SCZ GWAS data set (Ripke et al., 2013) were 
classified into four different categories: (i) eSNP: if they affect gene expression of specific 
transcripts; (ii) CRE: if they lie within a CRE region; (iii) eSNP in a cis regulatory element 
(creSNP); or, (iv) functionally unannotated variants (FUV) if they did not clustered to any of 
the above categories (Table S4). Among SCZ nominally associated loci at P ≤ 10−3 (n = 
42,253 SNPs,), 37.3% were grouped into the eSNP category (n = 15,762) (Table 1). Among 
this 37.3%, 4.9% were in active promoters, 9.6% in active enhancers, 3.5% in DHS, 1.0% in 
poised promoters and 1.5% in repressed enhancers. Relative enrichments for the categories 
were calculated using an empirical cumulative distribution of the GWAS P values after 
controlling for genomic inflation as described previously (Schork et al., 2013). Across all P 
value thresholds tested, the largest enrichment of GWAS SNPs occurs in the following 
categories: eSNPs and three types of CREs, active promoters, active enhancers and DHS 
(Table 1; Figure 1). Despite having fewer SNPs, enrichment is greater when the combined 
creSNP functional category is analyzed for all types of CREs (CRE range: 1.58 – 7.08 fold; 
creSNP range: 4.03 – 29.51 fold). This indicates that SCZ-associated variants are enriched 
for SNPs that have stronger support for a functional role (creSNP). Higher enrichment of the 
creSNP in comparison to CRE categories alone is found for the individual, non-integrated, 
CRE and creSNP functional annotation categories (Figure S1; Table S5). Among the 
individual, non-integrated creSNP annotations, H3K4me1, an individual histone mark of 
enhancers, in fetal and adult brain tissue, is the most enriched category (Table S5).
We provide a single number quantification of enrichment by calculating a categorical 
enrichment score (CES), which is a conservative estimate of the variance attributable to non-
null SNPs (Schork et al., 2013). The CES analysis indicates the following: first, SNPs that 
cluster within CRE, eSNP and creSNP functional annotation categories show higher CES 
compared to FUV (Figure 2). Second, the creSNP categories (scaled CES creSNP range: 
0.66 – 1) have higher CES than CREs (scaled CES CRE range: 0.11 – 0.29). Third, certain 
creSNP categories (active promoter, active enhancer and DHS) were the most enriched as 
measured by the CES. The enrichment was significant for active promoter and enhancer (for 
both CRE and creSNP), eSNP and DHS creSNP (all P ≤ 0.0001 by permutation). In the 
individual non-integrated functional categories, the H3K4me1 and H3K4me3 creSNP 
annotations in fetal brain tissue were the most enriched (26-fold compared to FUV category; 
P ≤ 0.0001 by permutation), as measured by the CES (Figure S2).
Differences in the extent of linkage disequilibrium (LD, estimated based on the sum r2) and 
minor allele frequency (MAF) were observed between the functional categories (Table S6). 
Since categories with higher average MAF or larger total amount of LD could spuriously 
appear enriched for SCZ association, we performed regression analysis which demonstrated 
that the effect of functional categories remains independently strong with an effect size rank 
that mirrors enrichment, despite the significant correlation among categories (Table S7). 
Furthermore, the enrichment was significant for all functional categories compared to FUV 
after removing SNPs with r2 > 0.1 and those that were <100 kb from a more strongly 
associated variant in the SCZ study (Table S6; Figure S3).
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Tissue specificity of functional annotation categories for GWAS enrichment
We then examined whether functional categories generated in brain tissue can better inform 
SCZ SNPs (show higher CES) compared to annotations derived from non-brain tissues. We 
used the following non-brain eSNP -- Lymphoblastoid cell line (LCL) (Xia et al., 2012), 
liver (Innocenti et al., 2011), peripheral blood mononuclear cells (PBMC) (Westra et al., 
2013), skin and adipose tissue (Grundberg et al., 2012) -- and CRE --skin, T-helper, liver, 
adipose tissue (Maurano et al., 2012; Zhu et al., 2013) -- functional categories to estimate 
CES for SCZ GWAS as described above. In addition we calculated CES using a previously 
published GWAS in rheumatoid arthritis (RA) (Stahl et al., 2010). The PBMC eSNP and T-
helper CRE functional categories were selected as positive controls for RA since 
immunological cells are implicated in its etiopathogenesis (Okada et al., 2014; Trynka et al., 
2013). The major histocompatibility complex (MHC) locus (chr6: 25–35Mb) was excluded 
from both GWAS datasets. The brain eSNP and CRE functional category showed the 
highest enrichment for SCZ (Figure 3A). In contrast, the blood/T-helper functional category 
showed the highest enrichment for RA. Within the brain and blood/T-helper related 
functional categories, the active promoter, active enhancer and DHS show the highest 
enrichment for SCZ and RA SNPs, respectively (Figure 3B).
Using functional annotations to prioritize risk loci in SCZ
The majority of SCZ genome-wide significant loci (index and SNPs in LD with them) are 
non-coding (Ripke et al., 2013). Given the enrichment of SCZ loci for eSNPs, we used the 
regulatory trait concordance (RTC) approach (Grundberg et al., 2012; Nica et al., 2010) to 
prioritize SNPs and genes within SCZ genome-wide significant loci. RTC scores ≥ 0.9 
indicate that overlapping eSNP and GWAS signals likely tag the same variant.
The genome-wide significant SNPs in Ripke et al. were mapped to 22 hotspot intervals 
(Table 2). We detected overlapping eSNP and GWAS signals at RTC ≥ 0.9 for 10 of 22 
intervals, four times the number expected by chance (2.2 expected in the top 10% of scoring 
intervals under the uniform distribution (Nica et al., 2010); P = 2 × 10−5). The SCZ-related 
eSNPs are associated with expression of 17 genes (3 intervals had RTC scores with eSNPs 
of > 0.9 for more than one gene). Given the enrichment of SCZ loci for creSNPs, we 
examined whether any of the 17 SCZ-associated eSNPs (and tag SNPs within 500kb and r2 
> 0.8) lie within the most enriched CRE categories (active promoter, active enhancer and 
DHS). Thirteen eSNPs out of the 17 are localized within such a CRE (Table 2; Figure 4). 
The expression of 5 genes is associated with loci within enhancers (C10orf32, CACNA1C, 
NGEF, RP11–490G2.2 and SDCCAG8). Gene expression of AS3MT is influenced by an 
eSNP that lies within the promoter region. The expression level of the remaining genes 
(NT5C2, GATAD2A, HAPLN4, GNL3, NEK4, SPCS1 and TYW5) is associated with multiple 
eSNPs within both promoter and enhancer sequences.
Functional annotations identify risk variants in CACNA1C that lie within putative 
enhancers and affect gene expression
The step-wise approach described above (Table 2; Figure 4) allows us to formulate a 
testable hypothesis for the mechanism through which some variants might increase risk for 
SCZ. For example, the CACNA1C index SNP (rs1006737) and eSNP (rs758170) are in close 
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proximity (16.2 kb) and have an RTC score of 1. Furthermore, the risk allele is associated 
with decreased CACNA1C gene expression (P = 1.88 × 10−5 at FDR 0.7%).
We identified 4 SNPs (rs2159100, rs12315711, rs11062170, rs4765905) that are in perfect 
LD with rs758170 and rs1006737, and lie within two predicted enhancers (spanning 1.4Kb 
and 1.85Kb), ∼185Kb downstream from the gene’s TSS (Figure 5A, Figure 5B). To identify 
whether the predicted enhancer region might be capable of forming promoter–enhancer 
loops, we mapped its physical interaction with the CACNA1C TSS in human dorsolateral 
prefrontal cortex (n = 6) and hiPSC derived-neurons by chromosome conformation capture 
(3C) assay (Mitchell et al., 2013) (Table S8, S9). In addition, this approach allows us to 
dissect the LD complexity of the region and identify variants with additional support for a 
functional role. Of the 17 restriction site regions tested, only one displayed an increased 
interaction with the TSS in human postmortem tissue (Primer #4 in Figure 5A–D). This 
enhancer region includes rs2159100 (MAF = 0.35, GWAS P value = 1.1 × 10−10) and 
rs12315711 (MAF=0.35, GWAS P value = 1.1 × 10−10) and demonstrates increased 
interaction frequency with the CACNA1C promoter (F (16, 83) = 5.52, P = 8 × 10−8). The 
rs2159100/rs12315711 3C interaction was confirmed in hiPSC derived-neurons (Figure 5D). 
In addition to being in an enhancer region, rs2159100 also co-localizes with a 600bp DHS 
region. Thus, we examined its effect on transcriptional activity in in vitro experiments. 
Compared to the reference rs2159100 C allele, the risk T variant is associated with 
decreased transcriptional activity in HEK-293 and Neuro-2a cells (42% (P < 0.0001) and 
23% (P < 0.05) reduction in luciferase activity, respectively) (Figure 5E).
DISCUSSION
We have demonstrated that SCZ associated loci are enriched for certain functional 
annotation categories. As reported previously, we found enrichment with eSNPs (Richards 
et al., 2012) and CRE annotations highlighting active regulatory regions (Trynka et al., 
2013). Here we demonstrate for the first time that integrative analysis of eSNPs with CRE 
epigenomic annotations identifies greater enrichment of risk loci compared to eSNPs or 
CREs alone. Given that eSNP (Dimas et al., 2009; Fairfax et al., 2012; Gibbs et al., 2010; 
Nica et al., 2011) and CRE-mediated epigenetic regulation (Cheung et al., 2010; Heintzman 
et al., 2009; Maurano et al., 2012) is often specific for tissue and even cell type, our findings 
add to the growing evidence supporting the importance of studying the human brain tissue 
for functional genomics analysis in neuropsychiatric illnesses.
The strongest SCZ associated enrichment was observed in fetal and adult brain creSNP 
annotations for enhancers. Previous studies have established the important regulatory role of 
the enhancers on transcriptome organization during neurodevelopment and adulthood 
(Andersson et al., 2014; Visel et al., 2013; Wenger et al., 2013). Overall, these findings 
suggest that risk allele specific alterations in enhancers could affect the proper 
spatiotemporal organization of the transcriptome that when combined with other 
perturbations leads to SCZ.
We have used a step-wise approach for defining functional enrichment and, in so doing, 
were led to a mechanistic hypothesis (of an interaction between disease signal, expression 
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signal and an enhancer) about the formation of chromosome loops between the enhancer and 
promoter. We experimentally validated these long-range interactions in human brain tissue 
and hiPSC derived-neurons for a gene that has been strongly associated with 
neuropsychiatric disorders. More specifically CACNA1C, a subunit of the L-type calcium 
channel, is one of the most widely reproduced associations, first identified in bipolar 
disorder (2011; Ferreira et al., 2008; Sklar et al., 2008), but subsequently also shown to be 
strongly associated with SCZ (Ripke et al., 2013). The association signal is in the middle of 
an intron, and does not suggest any immediate functional possibilities. In addition, the 
associated region is large (154.7 kb) and contains multiple implicated SNPs due to local LD 
patterns (216 SNPs with P < 10−3). We have now demonstrated in post-mortem human 
brain, and hiPSC derived-neurons, a specific interaction of a narrow, 1.4 kb region (which is 
an enhancer) with the proximal gene promoter by chromosome conformation capture. 
Furthermore, the risk variant is associated with reduced CACNA1C gene expression and 
transcriptional activity in the eSNP and in vitro experiments, respectively. Another recent 
study reported that CACNA1C rs1006737 (or rs2159100) is associated with decreased gene 
expression (Gershon et al., 2013), similar to our findings, although this is not consistently 
observed (Bigos et al., 2010). Since the initial report of CACNA1C association with bipolar 
disorder (Ferreira et al., 2008), there has been follow up with studies that report effects on 
functional connectivity in attention and emotion networks, cognitive performance and 
personality traits in SCZ and bipolar disorder (Bigos et al., 2010; Erk et al., 2010; Hori et al., 
2012; Paulus et al., 2013; Radua et al., 2013; Roussos et al., 2013; Roussos et al., 2011; 
Tesli et al., 2013).
Two out of the 17 genes identified through the RTC approach are calcium channels subunit 
genes (CACNA1C and CACNB2). We note that calcium channel subunits have been 
previously implicated in GWAS of bipolar disorder (Ferreira et al., 2008; Lee et al., 2011; 
Sklar et al., 2011; Sklar et al., 2008), SCZ (Ripke et al., 2013) and cross-disorder analyses 
(2013). In addition, an enrichment of rare disruptive variants in calcium channel subunits 
was reported in a recent exome sequencing study (Purcell et al., 2014). CACNA1C codes for 
Cav1.2, the most abundant neuronal L-type calcium channel (Obermair et al., 2004). The 
α1c subunit (CACNA1C) forms the transmembrane pore and directly interacts with the 
intracellular β2 subunit (CACNB2). The cytosolic β2 subunit has a major role in stabilizing 
the α1 subunit conformation and delivering it to the cell membrane by its ability to mask an 
endoplasmic reticulum retention signal in the α1 subunit (Bichet et al., 2000). Calcium-
mediated signaling has an important role on neuronal differentiation by regulating axonal 
growth and guidance and this process is also controlled by glutamatergic signaling 
(Rosenberg and Spitzer, 2011). It is possible that altered tuning in calcium-mediated 
signaling triggered by Cav1.2 and glutamatergic neurotransmission (Fromer et al., 2014; 
Purcell et al., 2014), could lead to alterations in the rate of axon outgrowth and pathfinding, 
resulting in inefficient neuronal wiring in SCZ.
While our approach can identify functional categories with higher enrichment compared to 
FUV categories, we still observe a deviation from the null for the FUV category, indicating 
multiple SCZ-associated loci that were not captured through our current functional 
annotation categories. Clearly current databases do not yet capture all types of functional 
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variants, including sites of DNA methylation and hydroxymethyaltion (Lister et al., 2013), 
as well as additional CREs such as insulators (Herold et al., 2012).
Furthermore, there is relatively low genomic resolution of current functional categories and 
many additional alternative putative mechanisms, such as transcriptional regulation through 
small and long non-coding RNAs and alternative splicing, likely mediate the effect of some 
non-coding risk alleles.
In conclusion, these results suggest a tissue-specific regulatory role for many SCZ 
associated common loci. While this paper was under review, a mega-analyses by the 
Psychiatric Genomic Consortium (PGC) in SCZ on over 80,000 cases and controls was 
published (2014). In the new PGC GWAS, 22 out of 24 loci remain genome-wide 
significant. In addition, 19 out of the 24 SNPs presented in Table 2 were in LD (r2 ≥ 0.3) 
with a genome-wide significant PGC index SNP. Our analysis provides a framework for 
future integrative analysis of additional data sets to generate testable hypotheses and derive 
mechanistic insights for SCZ associated variants.
EXPERIMENTAL PROCEDURES
A brief description of key methods and sample description are provided below, whereas 
complete details are found in the Extended Experimental Procedures.
GWAS data sets
A large published SCZ GWAS data set (Ripke et al., 2013) in the form of summary statistic 
P values was obtained from public access website (https://pgc.unc.edu/). A previously 
published GWAS data set in rheumatoid arthritis (Stahl et al., 2010) was obtained through 
collaboration with investigators in the form of summary statistic P values. For all the 
analyses presented here, the major histocompatibility complex (MHC) locus (chr6: 25–
35Mb) was excluded from both GWAS datasets.
eSNP data sets
Brain eSNPs were generated using the gene expression and genotyping data of Caucasian 
samples, included in the Braincloud (Colantuoni et al., 2011) (GEO accession number: 
GSE30272), NIA/NIH (Gibbs et al., 2010) (GEO accession number: GSE15745) and 
Harvard Brain Tissue Resource Center (HBTRC) (Zhang, 2013) (GEO accession number: 
GSE44772) datasets (Table S1). The following non-brain eSNP datasets were downloaded 
from public access websites: LCL (Xia et al., 2012) (http://www.bios.unc.edu/research/
genomic_software/seeQTL/), liver (Innocenti et al., 2011) (http://www.scandb.org/), 
peripheral blood mononuclear cells (PBMC) (Westra et al., 2013) (http://genenetwork.nl/
bloodeqtlbrowser), skin (Grundberg et al., 2012) and adipose tissue (Grundberg et al., 2012) 
(http://www.muther.ac.uk/Data.html).
cis regulatory element annotations
Multiple CRE annotations were used in the current study (Table S2, S3). ChIP-seq and DHS 
data generated as part of the ENCODE (Maurano et al., 2012) and REMC (Zhu et al., 2013) 
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projects for human brain/neuron (Table S2), T - helper cells, liver, skin and adipose tissue 
were downloaded from the NCBI repository (http://www.ncbi.nlm.nih.gov/geo/roadmap/
epigenomics/). Additional data for the dorsolateral prefrontal cortex after fluorescence-
activated cell sorting (FACS) were generated as described previously (Cheung et al., 2010; 
Shulha et al., 2013; Shulha et al., 2012) (Table S3).
Definition of functional datasets
All SNP coordinates described here are relative to UCSC hg19. The functional datasets used 
in the current study were divided into 3 groups: eSNP, CRE and creSNP (eSNP in a cis 
regulatory element).
1. eSNP: The brain eSNP dataset was generated by including all significant cis eSNPs 
derived from each eSNP analyses. For the non-brain eSNPs (LCL, liver, skin, 
PBMC and adipose tissue), we used the list of cis eSNPs generated as described 
previously (Grundberg et al., 2012; Innocenti et al., 2011; Westra et al., 2013; Xia 
et al., 2012) at FDR 10%.
2. CRE: The ChIP-seq and DHS significant peaks were clustered into subgroups 
based on assay and origin of tissue (Figure S4). We integrated multiple CRE 
subgroup annotations for generating functional annotations defining active 
promoters (overlap of H3K4me3 with H3K9ac or H3K27ac), poised promoters 
(overlap of H3K4me3 with H3K27me3), active enhancers (overlap of H3K4me3 
with H3K9ac or H3K27ac), repressed enhancers (overlap of H3K4me1 with 
H3K27me3) and open chromatin (DHS).
3. creSNP: The creSNP functional dataset was defined as the eSNPs that lie within 
different CRE subcategories.
GWAS Positional Annotation
We used a mixed approach for assigning the GWAS SNPs into functional categories. For the 
eSNP functional category, we leveraged the eSNP dataset in the densely mapped 1000G to 
identify the GWAS studied SNP that was tagged, as a result of LD. For generating the CRE 
or creSNP functional categories we used a positional approach (ignoring the annotation 
categories of SNPs in LD with the tag SNP). This mixed model allows us to capture all 
possible SNPs that affect gene expression (tag or SNPs in LD), followed by positional 
selection of SNPs that lie within putative regulatory DNA regions. GWAS SNP that did not 
fit in any functional category was assigned as the FUV category. The Table S4 describes the 
count of SCZ for each functional brain category.
Quantification of Enrichment
Stratified Q-Q plots were generated for assessment of the similarity or differences between 
the empirical cumulative distribution function of the functional and FUV datasets. In the 
stratified Q-Q plots, the enrichment of SCZ SNPs for a specific functional category is 
observed as a horizontal deflection from the FUV category. The quantification of 
enrichment for each functional category was done using the CES (mean (z2 – 1)), as 
described previously (Schork et al., 2013). The CES provides a summary score of category-
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specific enrichment where the mean is taken over all SNP z-scores in the given category. 
For each functional category, the statistical significance of CES was evaluated by 
permutation on a combined 10,000 randomized set of CREs and eSNPs.
Regulatory Trait Concordance score
The likelihood of a shared functional effect between a SCZ genome-wide significant SNP 
and an eSNP was assessed by the RTC approach (Grundberg et al., 2012; Nica et al., 2010). 
RTC score ranges from 0 to 1, with values ≥ 0.9 indicating the GWAS signal and eSNP tag 
the same underlying signal, as demonstrated previously (Grundberg et al., 2012; Nica et al., 
2010).
Chromosome Conformation Capture
Postmortem prefrontal cortex brain tissue for cases with SCZ and controls was obtained 
from the University of Maryland and pair-matched for age, sex, PMI, and pH (n = 3/group) 
(Table S8). Chromosome conformation capture (3C) was performed as described in a 
recently published protocol applicable to postmortem brain (Mitchell et al., 2014). Physical 
looping interactions were quantified with PCR. Primers were designed less than 120 bp from 
the HindIII or NcoI restriction site (Table S9). The PCR products were resolved on a 2% 
agarose gel and the level of interaction between two primers was measured 
semiquantitatively using band intensities normalized with the background (raw 3C 
interaction) with ImageJ (Schneider et al., 2012). For each library (HindIII and NcoI) in the 
human postmortem brain tissue studies, we transformed the raw 3C interaction to Z scores, 
followed by scaling (0 to 1) (Scaled 3C interaction). All 3C PCR products were sequence 
verified and the interactions were not present in the no ligase and water controls. For 
primers #2, #4 and #5, physical looping interactions were further quantified with qPCR 
using an ABI Prism 7900 (Applied Biosystems). The reactions were run in triplicate for each 
sample and DNA PCR product was measured through SYBR Green I (Life Technologies).
Human induced pluripotent stem cells differentiation to neurons
Human induced pluripotent stem cells (hiPSCs) were derived from fibroblasts of a control 
sample (GM03651) as described previously (Brennand et al., 2011). hiPSC derived-neurons 
were differentiated for ∼6 weeks in neural differentiation media. The majority of forebrain 
hiPSC neurons are VGLUT1-positive, and so are presumably glutamatergic, although 
approximately 30% of neurons are GAD67-positive (GABAergic) (Brennand et al., 2011).
Transient Transfection and Luciferase Assays
We constructed luciferase reporter plasmids by cloning the regulatory sequence containing 
rs2159100 into the pGL4.24 vector (Promega) upstream of the minP. HEK293 cells or 
Neuro-2a cells (40%–60% confluent) were transfected with each construct (500 ng) and the 
Renilla luciferase expression vector pRL-TK (200 ng; Promega). The luciferase activity in 
the cell lysates was determined using the Dual Luciferase Reporter System (Promega). 
Firefly luciferase activities were normalized to that of Renilla luciferase and expression 
relative to the activity of the rs2159100 C allele was noted.
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Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Stratified Q-Q plots for eSNP, CRE and creSNP in (a) active promoter, (b) active enhancer, 
(c) DHS, (d) poised promoter and (e) repressed enhancer functional annotation categories. 
The numbers for each functional category (blue box: creSNP; green box: CRE) illustrate the 
estimated increase in terms of the proportion of p-values expected below a genome-wide 
significant P value (P < 5 × 10−8; red dashed line) compared to the functionally unannotated 
variant (FUV) category. The estimated enrichment for eSNPs is 14.1. For all functional 
categories, enrichment is greater when the creSNP functional category is analyzed relative to 
CREs. All summary statistics were corrected for inflation by using the FUV inflation 
control. The major histocompatibility complex locus (chr6: 25–35Mb) was excluded from 
the SCZ dataset.
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Figure 2. 
Categorical enrichment for the combined functional annotations as measured by the CES. 
On the left side, we show the observed enrichment (red dashed lines) against the null 
distribution (gray density plots). For each functional category, we performed 10,000 
permutations to calculate the null distribution of enrichment for comparison to observed 
categorical enrichment. Functional categories with empirical P values that survived 
Bonferroni multiple testing correction are in bold (P corrected: 0.05 / 11 = 4.5 × 10−3). The 
number is parenthesis indicate the number of SNPs per annotation category. On the right 
side, the barplot illustrates the scaled CES for each functional category. creSNPs are 
illustrated in blue color, eSNPs in red, CREs in green and FUV in black. The CES are scaled 
using the maximum value across functional categories. All summary statistics were 
corrected for inflation by using the functionally unannotated variant (FUV) inflation control.
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Figure 3. 
Categorical enrichment in the SCZ and RA GWAS datasets for eSNPs and CREs (brain, 
LCL/T-helper, liver, PBMC/T-helper, skin and adipose tissue). For each eSNP-CRE 
combination, the (a) average value of the CES across all functional categories (active 
promoter, active enhancer, DHS, poised promoter and repressed enhancer) or (b) individual 
value was calculated. For each GWAS dataset, the CES were scaled using the maximum 
value across functional categories. The brain and blood/T-helper related eSNP and CRE 
functional category showed the highest enrichment for SCZ (blue) and RA (red) SNPs, 
respectively. All summary statistics were corrected for inflation by using the functionally 
unannotated variant (FUV) inflation control. *P < 0.05, **P < 0.01 by nonparametric Mann-
Whitney among the most enriched category and the rest of functional categories for each 
GWAS dataset. AP: active promoter; AE: active enhancer; PP: poised promoter; RE: 
repressed enhancer.
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Figure 4. 
Functional genomic analysis for the SCZ genome-wide significant loci. Layer 1 shows the 
24 genome-wide significant loci. Green lines illustrate loci with -log10 P value ≤ 10 and red 
lines show loci with -log10 P value > 10. Layer 2 (eSNP) illustrates which of the 24 
significant loci had eSNP with RTC ≥ 0.9. Layers 3–5 show whether eSNPs (and tag SNPs 
with r2 > 0.8 within 500kb) lie within active promoter (layer 3; Promoter), active enhancer 
(layer 4; Enhancer) or DNase I hypersensitive site (layer 5; DHS). Genes affected by 
functional SNPs are illustrating outside the circo. In black fonts are genes affected by eSNP. 
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In red fonts are genes affected by creSNPs (within active promoter, active enhancer or 
DHS).
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Figure 5. 
A physical interaction between the CACNA1C promoter and an enhancer region was 
confirmed by chromosome conformation capture (3C). (a) Part of the genomic region of 
CACNA1C (chr12:2,303,497–2,419,832) is displayed. The index SNP (red line; rs1006737), 
eSNP (orange line; rs758170) and tag SNPs (blue line; r2 > 0.8 within 500kb) that lie within 
CREs (enhancer and DHS) are illustrated. The index SNP and SNPs in LD with them are 
associated with lower CACNA1C gene expression. 3C–PCR primers were designed at the 
CACNA1C TSS and multiple regions (primers #1–17). A 3C physical interaction between 
the CACNA1C TSS and primer #4 was found in 3C libraries made from postmortem brain 
tissue (n = 6) (F (16, 83) = 5.52, P = 8 × 10-8). (b) More detailed view of the associated 
region (chr12:2,344,353–2,362,387). The primer #4 includes the rs2159100 creSNP (GWAS 
P value=1.1 × 10-10), which lies within an active enhancer (green box) and DHS (orange 
box). (c) 3C–qPCR shows increased interaction for primer #4 in libraries made from 
postmortem brain tissue (n = 6) (F (2, 15) = 4.54, P = 0.029). (d) Gel images are shown for 
primer #4 for 3C interactions using prefrontal cortex libraries in controls and SCZ and 
hiPSC derived-neurons. The red arrow shows the 3C interaction band. All 3C PCR products 
were sequence verified and the interactions were not present in the no ligase (-L) and water 
(W) controls. (e) The rs2159100 T risk allele (position 257 in the construct: 257T) affects 
the relative luciferase activity in HEK-293 and Neuro-2a cells compared to the C allele 
(257C). Data show the mean and standard error of mean. *P < 0.05, ****P < 0.0001 by 
unpaired t-test.
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